GBA1 and Lewy body dementia: While the additional inclusion of DLB participants and the inclusion of different GBA1 variants pose strengths of the present analyses, we acknowledge the following limitations: (I) The measurement of targeted single sphingolipid isoform (d18:1, 18:0) instead of several isoforms limits the detection of effects coming from long-chain isoforms.